lorazepam has been researched along with scopolamine hydrobromide in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (25.58) | 18.7374 |
1990's | 13 (30.23) | 18.2507 |
2000's | 15 (34.88) | 29.6817 |
2010's | 4 (9.30) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bellville, JW; Conner, JT; Graham, CW; Katz, RL; Pagano, RR; Schehl, D | 1 |
Knopman, D | 1 |
Iversen, SD; Rupniak, NM; Samson, NA; Steventon, MJ | 1 |
Curran, HV; Lader, M; Schifano, F | 1 |
Hui, PW; Jones, RD; Kapoor, SC; Mackillop, A; Merridew, CG; Moffatt, C; Warren, SJ | 1 |
Bean, VE; Butterworth, JF; Royster, RL | 1 |
Cohen, RM; Mellow, AM; Murphy, DL; Newhouse, PA; Sunderland, T; Tariot, PN; Thompson, K; Weingartner, H | 1 |
Bergstrom, RG; Meatherall, RC; Rosenbloom, M; Thomson, IR | 1 |
Auvinen, J; Korttila, K; Levänen, J | 1 |
Burton, AJ | 1 |
Ritchie, JA; Truelove, SC | 1 |
Ahlquist, J; Brown, MW; Rose, D | 1 |
Nilprapussorn, P | 1 |
Lumley, J; Morgan, M; Puchihewa, VG; Whitwam, JG | 1 |
Cole, BJ; Jones, GH | 1 |
Duka, T; Redemann, B; Voet, B | 1 |
Curran, HV; Schifano, F | 1 |
Overmier, JB; Savage, LM; Stanchfield, MA | 1 |
Bahro, M; Molchan, SE; Schreurs, BG; Sunderland, T | 1 |
Duka, T; Ott, H; Rohloff, A; Voet, B | 1 |
Curran, HV; Dalton, JA; Lader, MH; Pooviboonsuk, P | 1 |
Burke, AM; Gibbs, RB; Johnson, DA | 1 |
Bishop, KI; Curran, HV | 1 |
Dolan, RJ; Friston, KJ; Henson, RN; Morris, JS; Thiel, CM | 1 |
Battaglia, F; Boroojerdi, B; Cohen, LG; Muellbacher, W | 1 |
Albert, M; Cocchiarella, A; Dale, A; Firth, P; Greve, D; Holmes, J; Killiany, R; Lake, S; Lange, N; Rosas, HD; Rosen, B; Routledge, C; Sperling, R | 1 |
Dolan, RJ; Henson, RN; Thiel, CM | 1 |
Cohen, LG; Donchin, O; Madupu, G; Sawaki, L; Shadmehr, R | 1 |
Griffiths, RR; Mintzer, MZ | 3 |
Lange, N | 1 |
Blake, D; Chelonis, JJ; Dornhoffer, J | 1 |
Curran, HV; Kamboj, SK | 2 |
Gilles, C; Luthringer, R | 1 |
Lamme, VA; Scholte, HS; van der Hoort, BJ; van Gaal, S; van Loon, AM | 1 |
De Meyer, G; Dornhoffer, JL; Pauwels, G; Van de Heyning, PH; Vanspauwen, R; Weerts, AP; Wuyts, FL | 1 |
2 review(s) available for lorazepam and scopolamine hydrobromide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacological models in healthy volunteers: their use in the clinical development of psychotropic drugs.
Topics: Apomorphine; Cognition Disorders; Dopamine Agonists; Excitatory Amino Acid Antagonists; GABA Modulators; Humans; Ketamine; Lorazepam; Memory Disorders; Models, Psychological; Muscarinic Antagonists; Panic Disorder; Psychotropic Drugs; Scopolamine; Tryptophan | 2007 |
24 trial(s) available for lorazepam and scopolamine hydrobromide
Article | Year |
---|---|
Lorazepam, hyoscine and atropine as i.v. surgical premedicants.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety; Atropine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Infusions, Parenteral; Lorazepam; Male; Mental Recall; Middle Aged; Preanesthetic Medication; Scopolamine | 1978 |
Unaware learning versus preserved learning in pharmacologic amnesia: similarities and differences.
Topics: Adolescent; Adult; Amnesia; Female; Humans; Learning; Lorazepam; Male; Psychometrics; Reaction Time; Scopolamine; Task Performance and Analysis | 1991 |
Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood.
Topics: Adult; Affect; Anxiety; Double-Blind Method; Female; Flicker Fusion; Humans; Hypnotics and Sedatives; Lorazepam; Male; Memory Disorders; Middle Aged; Models, Psychological; Psychomotor Performance; Salivation; Scopolamine; Vision, Ocular | 1991 |
Effect of premedication on arterial blood gases prior to cardiac surgery.
Topics: Administration, Oral; Adult; Carbon Dioxide; Female; Heart Valves; Humans; Hydrogen-Ion Concentration; Injections, Intramuscular; Lorazepam; Male; Middle Aged; Morphine; Oxygen; Partial Pressure; Preanesthetic Medication; Randomized Controlled Trials as Topic; Scopolamine | 1990 |
Premedication determines the circulatory responses to rapid sequence induction with sufentanil for cardiac surgery.
Topics: Anesthesia, Intravenous; Anesthetics; Coronary Artery Bypass; Fentanyl; Hemodynamics; Humans; Lorazepam; Preanesthetic Medication; Scopolamine; Sufentanil | 1989 |
The effects of acute scopolamine in geriatric depression.
Topics: Aged; Alzheimer Disease; Clinical Trials as Topic; Cognition; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Emotions; Female; Humans; Lorazepam; Male; Middle Aged; Parasympathetic Nervous System; Personality Inventory; Psychiatric Status Rating Scales; Psychological Tests; Psychomotor Performance; Receptors, Cholinergic; Receptors, Muscarinic; Scopolamine | 1988 |
Premedication and high-dose fentanyl anesthesia for myocardial revascularization: a comparison of lorazepam versus morphine-scopolamine.
Topics: Anesthesia, Intravenous; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Fentanyl; Humans; Lorazepam; Morphine; Myocardial Revascularization; Preanesthetic Medication; Random Allocation; Scopolamine | 1988 |
Recalled apprehension after premedication with lorazepam.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Diazepam; Female; Humans; Lorazepam; Memory; Mental Recall; Opium; Postoperative Period; Preanesthetic Medication; Scopolamine; Sleep Stages | 1982 |
Comparison of various treatments for irritable bowel syndrome.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Colonic Diseases, Functional; Dietary Fiber; Drug Combinations; Drug Therapy, Combination; Female; Fluphenazine; Humans; Lorazepam; Male; Middle Aged; Nortriptyline; Phenethylamines; Random Allocation; Scopolamine | 1980 |
Scopolamine and lorazepam exert different patterns of effects in a test battery assessing stages of information processing.
Topics: Adult; Affect; Attention; Double-Blind Method; Humans; Lorazepam; Memory; Photic Stimulation; Psychiatric Status Rating Scales; Psychometrics; Scopolamine; Task Performance and Analysis; Time Factors | 1995 |
Pharmacological models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on word valence ratings, priming and recall.
Topics: Adult; Affect; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Lorazepam; Male; Memory Disorders; Mental Recall; Middle Aged; Models, Psychological; Scopolamine; Verbal Learning | 1994 |
The effects of scopolamine, lorazepam, and glycopyrrolate on classical conditioning of the human eyeblink response.
Topics: Adult; Blinking; Conditioning, Classical; Double-Blind Method; Female; GABA Modulators; Glycopyrrolate; Humans; Lorazepam; Male; Muscarinic Antagonists; Scopolamine | 1995 |
The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills.
Topics: Adult; Arousal; Attention; Carbolines; Cognition; Double-Blind Method; Electroencephalography; GABA Antagonists; GABA Modulators; GABA-A Receptor Antagonists; Humans; Lorazepam; Memory; Mental Processes; Parasympatholytics; Psychomotor Performance; Scopolamine | 1996 |
An investigation of the effects of benzodiazepine receptor ligands and of scopolamine on conceptual priming.
Topics: Adolescent; Adult; Female; Flumazenil; GABA Modulators; Humans; Lorazepam; Male; Memory; Middle Aged; Muscarinic Antagonists; Neuropsychological Tests; Scopolamine | 1998 |
Pharmacological modulation of behavioral and neuronal correlates of repetition priming.
Topics: Adolescent; Adult; Brain; Brain Mapping; Double-Blind Method; Drug Administration Routes; Drug Administration Schedule; Female; GABA Modulators; Humans; Learning; Lorazepam; Magnetic Resonance Imaging; Male; Muscarinic Antagonists; Neurons; Photic Stimulation; Reading; Scopolamine; Verbal Behavior; Word Association Tests | 2001 |
Mechanisms influencing acquisition and recall of motor memories.
Topics: Adolescent; Adult; Conditioning, Psychological; Dextromethorphan; Excitatory Amino Acid Antagonists; Female; GABA Modulators; Humans; Lamotrigine; Lorazepam; Male; Mental Recall; Middle Aged; Movement; Muscarinic Antagonists; Neuronal Plasticity; Psychomotor Performance; Scopolamine; Triazines | 2002 |
Lorazepam and scopolamine: A single-dose comparison of effects on human memory and attentional processes.
Topics: Adult; Anti-Anxiety Agents; Attention; Cognition; Color Perception; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lorazepam; Male; Memory; Memory, Short-Term; Muscarinic Antagonists; Neuropsychological Tests; Psychomotor Performance; Reaction Time; Scopolamine; Verbal Learning | 2003 |
What can modern statistics offer imaging neuroscience?
Topics: Alzheimer Disease; Brain Mapping; GABA Modulators; Hippocampus; Humans; Lorazepam; Magnetic Resonance Imaging; Male; Memory; Models, Statistical; Muscarinic Antagonists; Oxygen; Schizophrenia; Scopolamine | 2003 |
Stimulation of the semicircular canals via the rotary chair as a means to test pharmacologic countermeasures for space motion sickness.
Topics: Adolescent; Adult; Double-Blind Method; Female; GABA Modulators; Histamine H1 Antagonists; Humans; Lorazepam; Male; Meclizine; Muscarinic Antagonists; Promethazine; Scopolamine; Semicircular Canals; Space Motion Sickness; Treatment Outcome; Vestibular Function Tests | 2004 |
Drugs, memory, and metamemory: a dose-effect study with lorazepam and scopolamine.
Topics: Administration, Oral; Analysis of Variance; Anti-Anxiety Agents; Capsules; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Injections, Subcutaneous; Lorazepam; Memory; Mental Recall; Muscarinic Antagonists; Psychomotor Performance; Scopolamine; Time Factors | 2005 |
Scopolamine induces impairments in the recognition of human facial expressions of anger and disgust.
Topics: Adolescent; Adult; Anger; Depression, Chemical; Double-Blind Method; Emotions; Facial Expression; Female; Humans; Hypnotics and Sedatives; Lorazepam; Male; Memory; Muscarinic Antagonists; Psychomotor Performance; Recognition, Psychology; Scopolamine | 2006 |
Neutral and emotional episodic memory: global impairment after lorazepam or scopolamine.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Double-Blind Method; Emotions; Female; GABA Modulators; Humans; Lorazepam; Male; Memory; Muscarinic Antagonists; Scopolamine | 2006 |
Differential effects of scopolamine and lorazepam on working memory maintenance versus manipulation processes.
Topics: Adult; Analysis of Variance; Anti-Anxiety Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lorazepam; Male; Memory, Short-Term; Muscarinic Antagonists; Neuropsychological Tests; Psychomotor Performance; Reaction Time; Scopolamine; Time Factors | 2007 |
Pharmaceutical countermeasures have opposite effects on the utricles and semicircular canals in man.
Topics: Adult; Antiemetics; Female; Humans; Lorazepam; Male; Meclizine; Middle Aged; Promethazine; Reflex, Vestibulo-Ocular; Saccule and Utricle; Scopolamine; Semicircular Canals; Space Motion Sickness; Vestibular Function Tests | 2012 |
17 other study(ies) available for lorazepam and scopolamine hydrobromide
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Induction of cognitive impairment by scopolamine and noncholinergic agents in rhesus monkeys.
Topics: Amphetamine; Animals; Behavior, Animal; Cognition; Dronabinol; Lorazepam; Macaca mulatta; Male; Morphine; Phencyclidine; Scopolamine; Spatial Behavior; Yohimbine | 1991 |
Failure of intramuscularly administered lorazepam and scopolamine-morphine premedication to produce amnesic effects to supplement conduction anaesthesia.
Topics: Adult; Anesthesia, Conduction; Anti-Anxiety Agents; Atropine; Humans; Injections, Intramuscular; Lorazepam; Male; Memory; Meperidine; Morphine; Preanesthetic Medication; Scopolamine | 1980 |
Amnesia-producing drugs affect hippocampal frequency potentiation.
Topics: Amnesia; Animals; Evoked Potentials; Hippocampus; Humans; Lorazepam; Propranolol; Rats; Scopolamine | 1983 |
A new technique of balanced anaesthesia II. Morphine, hyoscine and alloferin.
Topics: Adolescent; Adult; Alcuronium; Anesthesia, Intravenous; Diazepam; Drug Interactions; Female; Humans; Lorazepam; Middle Aged; Morphine; Preanesthetic Medication; Scopolamine; Time Factors; Toxiferine | 1984 |
Respiratory effects of Minaxolone.
Topics: Anesthesia, Intravenous; Anesthetics; Apnea; Atropine; Female; Humans; Lorazepam; Lung Volume Measurements; Papaverine; Preanesthetic Medication; Pregnanes; Pregnanolone; Respiration; Scopolamine | 1980 |
Double dissociation between the effects of muscarinic antagonists and benzodiazepine receptor agonists on the acquisition and retention of passive avoidance.
Topics: Animals; Atropine; Avoidance Learning; Diazepam; GABA-A Receptor Agonists; Lorazepam; Male; Memory; Muscarinic Antagonists; Rats; Rats, Wistar; Scopolamine | 1995 |
The effects of scopolamine, diazepam, and lorazepam on working memory in pigeons: an analysis of reinforcement procedures and sample problem type.
Topics: Animals; Columbidae; Conditioning, Operant; Diazepam; Discrimination Learning; Dose-Response Relationship, Drug; Female; Lorazepam; Memory, Short-Term; Reinforcement, Psychology; Scopolamine | 1994 |
Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine.
Topics: Adult; Arousal; Diphenhydramine; Double-Blind Method; Electroencephalography; Evoked Potentials; Female; GABA Modulators; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Lorazepam; Male; Memory; Middle Aged; Muscarinic Antagonists; Scopolamine | 1998 |
Estrogen replacement attenuates effects of scopolamine and lorazepam on memory acquisition and retention.
Topics: Animals; Anti-Anxiety Agents; Avoidance Learning; Estradiol; Estrogen Replacement Therapy; Female; Learning; Lorazepam; Memory; Muscarinic Antagonists; Ovariectomy; Rats; Rats, Sprague-Dawley; Scopolamine | 1998 |
Mechanisms underlying rapid experience-dependent plasticity in the human visual cortex.
Topics: Adult; Animals; Dextromethorphan; GABA Modulators; Humans; Light; Lorazepam; Male; Muscarinic Antagonists; Neuronal Plasticity; Photic Stimulation; Receptors, GABA; Receptors, Muscarinic; Receptors, N-Methyl-D-Aspartate; Scopolamine; Visual Cortex | 2001 |
Functional MRI detection of pharmacologically induced memory impairment.
Topics: Adult; Anti-Anxiety Agents; Brain; Cross-Over Studies; Double-Blind Method; Humans; Image Processing, Computer-Assisted; Learning; Lorazepam; Magnetic Resonance Imaging; Male; Memory; Memory Disorders; Muscarinic Antagonists; Placebos; Scopolamine; Visual Cortex | 2002 |
Scopolamine but not lorazepam modulates face repetition priming: a psychopharmacological fMRI study.
Topics: Acetylcholine; Adjuvants, Anesthesia; Adolescent; Adult; Anti-Anxiety Agents; Emotions; Face; Female; Functional Laterality; Habituation, Psychophysiologic; Humans; Learning; Lorazepam; Male; Memory; Neuropsychological Tests; Pattern Recognition, Visual; Photic Stimulation; Psychomotor Performance; Scopolamine; Synaptic Transmission; Temporal Lobe; Visual Cortex | 2002 |
GABAA agonist reduces visual awareness: a masking-EEG experiment.
Topics: Adolescent; Adult; Analysis of Variance; Awareness; Dextromethorphan; Electroencephalography; Evoked Potentials, Visual; Excitatory Amino Acid Antagonists; Female; GABA Agonists; Humans; Lorazepam; Muscarinic Antagonists; Orientation; Perceptual Masking; Photic Stimulation; Reaction Time; Scopolamine; Time Factors; Visual Cortex; Visual Perception; Young Adult | 2012 |